Redesign Science
Pre-clinicalWe simulate biomolecular systems from first principles using physics-based atomic-level molecular dynamicsOur NUVO™ technology platform combines physics simulation with generative AI to serve our internal therapeutics pipelineWe develop first-in-class small molecule Targeted Protein Interaction Modulators (TPIM™)
Founded
2017
Focus
AI / Machine LearningDrug DiscoverySmall Molecules
About
We simulate biomolecular systems from first principles using physics-based atomic-level molecular dynamicsOur NUVO™ technology platform combines physics simulation with generative AI to serve our internal therapeutics pipelineWe develop first-in-class small molecule Targeted Protein Interaction Modulators (TPIM™)
Funding History
2Total raised: $29M
Series A$25MAndreessen HorowitzMar 15, 2023
Seed$4MKdT VenturesOct 15, 2021
Company Info
TypePrivate
Founded2017
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile